Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1992 Mar 1;282(Pt 2):605–614. doi: 10.1042/bj2820605

Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.

C Freeman 1, J J Hopwood 1
PMCID: PMC1130825  PMID: 1546976

Abstract

Glucosamine-6-sulphatase (6S) activity towards a series of radiolabelled heparin-derived trisaccharide substrates was determined in cultured human skin fibroblast and leucocyte homogenates, and in urine supernatants of normal individuals and patients affected with 6S deficiency [Sanfilippo D syndrome; mucopolysaccharidosis (MPS) type IIID]. The N-sulphated and N-acetylated derivatives of the trisaccharide substrate O-(alpha-glucosamine 6-sulphate)-(1----4)-L-O-(alpha-iduronic acid 2-sulphate)-(1----4)-D-O-2,5-anhydro[1-3H]mannitol 6-sulphate (GlcNH6S-IdoA2S-anM6S) were prepared by enzymic digestion of a pentasulphated tetrasaccharide isolated following the HNO2 deamination of heparin. Purified lysosomal enzymes and MPS-patient skin fibroblasts were used along with chemical degradation to confirm the structure of each of the substrates that were utilized to study the interaction of the enzyme activities required to degrade the highly sulphated regions of heparan sulphate. Human liver, skin fibroblast and urine 6S activities were separated by chromatofocusing into at least four and possibly up to six individual activities. 6S activities present in each of the tissues generally had similar catalytic properties, including Km values, pH optima and inhibition with NaCl, Na2SO4 and NaH2PO4. Leucocyte and skin fibroblast 6S activities towards GlcNAc6S-IdoA2S-anM6S were maximal at pH 4.1 and 3.9 respectively, with Km values of 2.8 microM and 0.9-1.7 microM respectively. Urine 6S activity towards GlcNAc6S-IdoA2S-anM6S was stimulated 30-fold by BSA at pH 3.9, which shifted the pH optimum from 5.1 to 4.2 and decreased the Km value at pH 4.2 from 4.0 microM to 0.5 microM. Residual 6S activity present in the skin fibroblast homogenates from MPS IIID patients was characterized for activity towards GlcNAc6S-IdoA2S-anM6S and observed to have similar pH optima and Km values to normal skin fibroblast 6S activities, although the residual 6S activity was less than 1% of the normal control range.

Full text

PDF
605

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BITTER T., MUIR H. M. A modified uronic acid carbazole reaction. Anal Biochem. 1962 Oct;4:330–334. doi: 10.1016/0003-2697(62)90095-7. [DOI] [PubMed] [Google Scholar]
  2. Basner R., Kresse H., von Figura K. N-Acetylglucosamine-6-sulfate sulfatase from human urine. J Biol Chem. 1979 Feb 25;254(4):1151–1158. [PubMed] [Google Scholar]
  3. Bielicki J., Freeman C., Clements P. R., Hopwood J. J. Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties. Biochem J. 1990 Oct 1;271(1):75–86. doi: 10.1042/bj2710075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bienkowski M. J., Conrad H. E. Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid. J Biol Chem. 1985 Jan 10;260(1):356–365. [PubMed] [Google Scholar]
  5. Carey W. F., Pollard A. C. Variability of fibroblast lysosomal acid hydrolases with reference to the detection of enzyme deficiencies. Aust J Exp Biol Med Sci. 1977 Jun;55(3):245–252. doi: 10.1038/icb.1977.19. [DOI] [PubMed] [Google Scholar]
  6. Clements P. R., Muller V., Hopwood J. J. Human alpha-L-iduronidase. 2. Catalytic properties. Eur J Biochem. 1985 Oct 1;152(1):29–34. doi: 10.1111/j.1432-1033.1985.tb09159.x. [DOI] [PubMed] [Google Scholar]
  7. Coppa G. V., Giorgi P. L., Felici L., Gabrielli O., Donti E., Bernasconi S., Kresse H., Paschke E., Mastropaolo C. Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new cases. Eur J Pediatr. 1983 Apr;140(2):130–133. doi: 10.1007/BF00441662. [DOI] [PubMed] [Google Scholar]
  8. Elliott H., Hopwood J. J. Detection of the Sanfilippo D syndrome by the use of a radiolabeled monosaccharide sulfate as the substrate for the estimation of N-acetylglucosamine-6-sulfate sulfatase. Anal Biochem. 1984 Apr;138(1):205–209. doi: 10.1016/0003-2697(84)90789-9. [DOI] [PubMed] [Google Scholar]
  9. Freeman C., Clements P. R., Hopwood J. J. Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization. Biochem J. 1987 Sep 1;246(2):347–354. doi: 10.1042/bj2460347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Freeman C., Hopwood J. J. Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties. Biochem J. 1987 Sep 1;246(2):355–365. doi: 10.1042/bj2460355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Freeman C., Hopwood J. J. Human liver glucuronate 2-sulphatase. Purification, characterization and catalytic properties. Biochem J. 1989 Apr 1;259(1):209–216. doi: 10.1042/bj2590209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Freeman C., Hopwood J. J. Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties. Biochem J. 1986 Feb 15;234(1):83–92. doi: 10.1042/bj2340083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Freeman C., Hopwood J. J. Sanfilippo D syndrome: estimation of N-acetylglucosamine-6-sulfatase activity with a radiolabeled monosulfated disaccharide substrate. Anal Biochem. 1989 Feb 1;176(2):244–248. doi: 10.1016/0003-2697(89)90303-5. [DOI] [PubMed] [Google Scholar]
  14. Gatti R., Borrone C., Durand P., De Virgilis S., Sanna G., Cao A., von Figura K., Kresse H., Paschke E. Sanfilippo type D disease: clinical findings in two patients with a new variant of mucopolysaccharidosis III. Eur J Pediatr. 1982 Mar;138(2):168–171. doi: 10.1007/BF00441147. [DOI] [PubMed] [Google Scholar]
  15. Glaser J. H., Conrad H. E. Chick embryo liver beta-glucuronidase. Comparison of activity on natural and artificial substrates. J Biol Chem. 1979 Jul 25;254(14):6588–6597. [PubMed] [Google Scholar]
  16. Glaser J. H., Conrad H. E. Multiple kinetic forms of beta-glucuronidase. J Biol Chem. 1980 Mar 10;255(5):1879–1894. [PubMed] [Google Scholar]
  17. Hopwood J. J., Elliott H. Detection of Morquio A syndrome using radiolabelled substrates derived from keratan sulphate for the estimation of galactose 6-sulphate sulphatase. Clin Sci (Lond) 1983 Sep;65(3):325–331. doi: 10.1042/cs0650325. [DOI] [PubMed] [Google Scholar]
  18. Hopwood J. J., Elliott H. Detection of the Sanfilippo type B syndrome using radiolabelled oligosaccharides as substrates for the estimation of alpha-N-acetylglucosaminidase. Clin Chim Acta. 1982 Mar 26;120(1):77–86. doi: 10.1016/0009-8981(82)90079-1. [DOI] [PubMed] [Google Scholar]
  19. Hopwood J. J., Elliott H. Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate. Clin Chim Acta. 1982 Aug 18;123(3):241–250. doi: 10.1016/0009-8981(82)90168-1. [DOI] [PubMed] [Google Scholar]
  20. Hopwood J. J., Elliott H., Muller V. J., Saccone G. T. Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity. Biochem J. 1986 Mar 15;234(3):507–514. doi: 10.1042/bj2340507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hopwood J. J., Elliott H. Radiolabelled oligosaccharides as substrates for the estimation of sulfamidase and the detection of the Sanfilippo type A syndrome. Clin Chim Acta. 1981 Apr 27;112(1):55–66. doi: 10.1016/0009-8981(81)90268-0. [DOI] [PubMed] [Google Scholar]
  22. Hopwood J. J., Elliott H. Selective depolymerisation of heparin to produce radio-labelled substrates for sulfamidase, 2-acetamido-2-deoxy-alpha-D-glucosidase, acetyl-CoA:2-amino-2-deoxy-alpha-D-glucoside N-acetyltransferase, and 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase. Carbohydr Res. 1981 May 1;91(2):165–190. doi: 10.1016/s0008-6215(00)86029-2. [DOI] [PubMed] [Google Scholar]
  23. Hopwood J. J., Elliott H. The diagnosis of the Sanfilippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity. Clin Chim Acta. 1981 Apr 27;112(1):67–75. doi: 10.1016/0009-8981(81)90269-2. [DOI] [PubMed] [Google Scholar]
  24. Hopwood J. J., Morris C. P. The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment. Mol Biol Med. 1990 Oct;7(5):381–404. [PubMed] [Google Scholar]
  25. Hopwood J. J., Muller V. Biochemical discrimination of Hurler and Scheie syndromes. Clin Sci (Lond) 1979 Sep;57(3):265–272. doi: 10.1042/cs0570265. [DOI] [PubMed] [Google Scholar]
  26. Hopwood J. J., Muller V., Pollard A. C. Post- and pre-natal assessment of alpha-L-iduronidase deficiency with a radiolabelled natural substrate. Clin Sci (Lond) 1979 Jan;56(6):591–599. doi: 10.1042/cs0560591. [DOI] [PubMed] [Google Scholar]
  27. Hopwood J. J. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin. Carbohydr Res. 1979 Mar;69:203–216. doi: 10.1016/s0008-6215(00)85765-1. [DOI] [PubMed] [Google Scholar]
  28. Hök M., Lindahl U., Hallén A., Bäckström G. Biosynthesis of heparin. Studies on the microsomal sulfation process. J Biol Chem. 1975 Aug 10;250(15):6065–6071. [PubMed] [Google Scholar]
  29. Kaplan P., Wolfe L. S. Sanfilippo syndrome type D. J Pediatr. 1987 Feb;110(2):267–271. doi: 10.1016/s0022-3476(87)80171-3. [DOI] [PubMed] [Google Scholar]
  30. Kresse H., Paschke E., von Figura K., Gilberg W., Fuchs W. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6822–6826. doi: 10.1073/pnas.77.11.6822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  32. Mahuran D., Clements P., Hopwood J. A rapid four column purification of 2-deoxy-D-glucoside-2-sulphamate sulphohydrolase from human liver. Biochim Biophys Acta. 1983 Jun 9;757(3):359–365. doi: 10.1016/0304-4165(83)90062-4. [DOI] [PubMed] [Google Scholar]
  33. Muller V. J., Hopwood J. J. Radiolabelled disaccharides for the assay of beta-D-glucuronidase activity and the detection of mucopolysaccharidosis type VII. Clin Chim Acta. 1982 Aug 18;123(3):357–360. doi: 10.1016/0009-8981(82)90182-6. [DOI] [PubMed] [Google Scholar]
  34. Robertson D. A., Callen D. F., Baker E. G., Morris C. P., Hopwood J. J. Chromosomal localization of the gene for human glucosamine-6-sulphatase to 12q14. Hum Genet. 1988 Jun;79(2):175–178. doi: 10.1007/BF00280560. [DOI] [PubMed] [Google Scholar]
  35. Robertson D. A., Freeman C., Nelson P. V., Morris C. P., Hopwood J. J. Human glucosamine-6-sulfatase cDNA reveals homology with steroid sulfatase. Biochem Biophys Res Commun. 1988 Nov 30;157(1):218–224. doi: 10.1016/s0006-291x(88)80035-4. [DOI] [PubMed] [Google Scholar]
  36. Shaklee P. N., Conrad H. E. Hydrazinolysis of heparin and other glycosaminoglycans. Biochem J. 1984 Jan 1;217(1):187–197. doi: 10.1042/bj2170187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shaklee P. N., Glaser J. H., Conrad H. E. A sulfatase specific for glucuronic acid 2-sulfate residues in glycosaminoglycans. J Biol Chem. 1985 Aug 5;260(16):9146–9149. [PubMed] [Google Scholar]
  38. Shively J. E., Conrad H. E. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry. 1976 Sep 7;15(18):3932–3942. doi: 10.1021/bi00663a005. [DOI] [PubMed] [Google Scholar]
  39. Siciliano L., Fiumara A., Pavone L., Freeman C., Robertson D., Morris C. P., Hopwood J. J., Di Natale P., Musumeci S., Horwitz A. L. Sanfilippo syndrome type D in two adolescent sisters. J Med Genet. 1991 Jun;28(6):402–405. doi: 10.1136/jmg.28.6.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weissmann B., Chao H., Chow P. A glucosamine O,N-disulfate O-sulfohydrolase with a probable role in mammalian catabolism of heparan sulfate. Biochem Biophys Res Commun. 1980 Nov 28;97(2):827–833. doi: 10.1016/0006-291x(80)90338-1. [DOI] [PubMed] [Google Scholar]
  41. Weissmann B., Chao H. Heparin trisaccharides with nonreducing 2-amino-2-deoxy-alpha-D-glucopyranosyl end-groups suitable as substrates for catabolic enzymes. Carbohydr Res. 1986 Oct 15;154:217–228. doi: 10.1016/s0008-6215(00)90034-x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES